{"id":17763,"date":"2018-02-13T15:27:00","date_gmt":"2018-02-13T14:27:00","guid":{"rendered":"https:\/\/www.chromacon.com\/news\/passage-du-procede-de-chromatographie-continue-capturesmb-de-chromacon-de-lechelle-laboratoire-a-lechelle-pilote-et-production\/"},"modified":"2026-09-01T09:28:33","modified_gmt":"2026-09-01T07:28:33","slug":"passage-du-procede-de-chromatographie-continue-capturesmb-de-chromacon-de-lechelle-laboratoire-a-lechelle-pilote-et-production","status":"publish","type":"post","link":"https:\/\/www.chromacon.com\/fr\/news\/passage-du-procede-de-chromatographie-continue-capturesmb-de-chromacon-de-lechelle-laboratoire-a-lechelle-pilote-et-production\/","title":{"rendered":"Passage du proc\u00e9d\u00e9 de chromatographie continue CaptureSMB\u00ae de ChromaCon de l&rsquo;\u00e9chelle laboratoire \u00e0 l&rsquo;\u00e9chelle pilote et production"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Zurich, Suisse \u2013 13 f\u00e9vrier 2018<\/strong> \u2013 ChromaCon AG annonce aujourd&rsquo;hui le succ\u00e8s de la mont\u00e9e en \u00e9chelle de son <strong>proc\u00e9d\u00e9 de chromatographie \u00e0 contre-courant p\u00e9riodique \u00e0 deux colonnes CaptureSMB\u00ae<\/strong> pour la <strong>purification d&rsquo;anticorps monoclonaux (mAb)<\/strong>, de l&rsquo;\u00e9chelle laboratoire \u00e0 l&rsquo;\u00e9chelle pilote et production industrielles.<\/p>\n\n<p class=\"wp-block-paragraph\">Le <strong>proc\u00e9d\u00e9 CaptureSMB<\/strong>, une technologie de capture \u00e0 contre-courant p\u00e9riodique \u00e0 deux colonnes optimis\u00e9e, a \u00e9t\u00e9 transf\u00e9r\u00e9 d&rsquo;un syst\u00e8me <strong>Contichrom\u00ae CUBE<\/strong> \u00e0 l&rsquo;\u00e9chelle laboratoire (ChromaCon, Zurich) vers un syst\u00e8me <strong>Contichrom\u00ae TWIN<\/strong> 100 fois plus grand (LEWA, Devens, MA). Les r\u00e9sultats confirment que la <strong>capture continue sur prot\u00e9ine A<\/strong> avec CaptureSMB peut \u00eatre mise \u00e0 l&rsquo;\u00e9chelle de mani\u00e8re fiable pour le bioproc\u00e9d\u00e9 industriel. <\/p>\n\n<p class=\"wp-block-paragraph\">Une \u00e9quipe conjointe de <strong>Bristol-Myers Squibb (Devens, MA)<\/strong>, <strong>ChromaCon (Zurich)<\/strong> et <strong>LEWA (Devens, MA)<\/strong> pr\u00e9sente ces r\u00e9sultats dans <em>BioProcess International<\/em> dans l&rsquo;article <a href=\"http:\/\/bpi.bioprocessintl.com\/scale-up-of-twin-column-periodic-counter-current-chromatography-for-monoclonal-antibody-purification\" target=\"_blank\" rel=\"noopener\">\u00ab Scale-Up of Twin-Column Periodic Counter-Current Chromatography for Monoclonal Antibody Purification \u00bb<\/a>.<\/p>\n\n<h3 class=\"wp-block-heading\">Mont\u00e9e en \u00e9chelle industrielle \u00e9prouv\u00e9e de la capture continue CaptureSMB<\/h3>\n\n<p class=\"wp-block-paragraph\">Les travaux de d\u00e9veloppement \u00e0 l&rsquo;\u00e9chelle laboratoire ont \u00e9t\u00e9 r\u00e9alis\u00e9s sur un syst\u00e8me <strong>Contichrom CUBE<\/strong>. Les donn\u00e9es de performance de ces <strong>exp\u00e9riences CaptureSMB \u00e0 petite \u00e9chelle<\/strong> ont pr\u00e9dit avec pr\u00e9cision le comportement du proc\u00e9d\u00e9 lors de son transfert \u00e0 <strong>l&rsquo;\u00e9chelle pilote et production<\/strong> sur la plateforme <strong>Contichrom TWIN<\/strong>, d\u00e9montrant une <strong>strat\u00e9gie de mont\u00e9e en \u00e9chelle robuste et transparente<\/strong> pour les fabricants biopharmaceutiques. <\/p>\n\n<p class=\"wp-block-paragraph\">Compar\u00e9 \u00e0 la <strong>chromatographie de capture par lots \u00e0 colonne unique<\/strong> conventionnelle, le proc\u00e9d\u00e9 CaptureSMB mis \u00e0 l&rsquo;\u00e9chelle a permis d&rsquo;obtenir :<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Une <strong>productivit\u00e9 2,5 fois sup\u00e9rieure<\/strong> (augmentation des grammes de mAb produits par litre de r\u00e9sine par heure)<\/li>\n\n\n\n<li>Une am\u00e9lioration de <strong>l&rsquo;utilisation de la r\u00e9sine de 67 % \u00e0 92 %<\/strong>, maximisant la valeur du support chromatographique<\/li>\n\n\n\n<li>Une <strong>r\u00e9duction d&rsquo;environ 50 % de la consommation de tampon<\/strong>, diminuant les co\u00fbts d&rsquo;exploitation et l&#8217;empreinte de l&rsquo;installation<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Ces gains de performance soutiennent l&rsquo;adoption du <strong>traitement en aval continu<\/strong> et de la <strong>capture \u00e0 deux colonnes<\/strong> dans la <strong>fabrication commerciale d&rsquo;anticorps monoclonaux<\/strong>.<\/p>\n\n<h3 class=\"wp-block-heading\">Point de vue d&rsquo;expert sur la chromatographie continue \u00e0 deux colonnes<\/h3>\n\n<p class=\"wp-block-paragraph\">Thomas M\u00fcller-Sp\u00e4th, directeur des op\u00e9rations de ChromaCon et coauteur de l&rsquo;\u00e9tude, a d\u00e9clar\u00e9 :<\/p>\n\n<p class=\"wp-block-paragraph\">\u00ab Les donn\u00e9es montrent clairement l&rsquo;avantage d&rsquo;un proc\u00e9d\u00e9 de capture continue \u00e0 deux colonnes \u00e0 l&rsquo;\u00e9chelle de production. Le processus de mont\u00e9e en \u00e9chelle fluide et transparent a \u00e9t\u00e9 facilit\u00e9 par la faible complexit\u00e9 du proc\u00e9d\u00e9 CaptureSMB \u00e0 deux colonnes. Il s&rsquo;agit \u00e9galement d&rsquo;un facteur important lors de la validation du proc\u00e9d\u00e9 et de la recherche d&rsquo;approbation r\u00e9glementaire. \u00bb<\/p>\n\n<p class=\"wp-block-paragraph\">Michael Bavand, directeur g\u00e9n\u00e9ral de ChromaCon, a ajout\u00e9 :<\/p>\n\n<p class=\"wp-block-paragraph\">\u00ab La validation de la performance du proc\u00e9d\u00e9 CaptureSMB \u00e0 l&rsquo;\u00e9chelle industrielle repr\u00e9sente une \u00e9tape importante pour l&rsquo;industrie du bioproc\u00e9d\u00e9. Avec nos partenaires, nous ouvrons la voie \u00e0 une adoption rapide des proc\u00e9d\u00e9s continus \u00e0 l&rsquo;\u00e9chelle industrielle. \u00bb<\/p>\n\n<h3 class=\"wp-block-heading\">Principaux avantages de CaptureSMB pour la purification d&rsquo;anticorps monoclonaux<\/h3>\n\n<p class=\"wp-block-paragraph\">Le succ\u00e8s de la mont\u00e9e en \u00e9chelle confirme CaptureSMB comme une puissante <strong>solution de chromatographie continue<\/strong> pour la capture de mAb, offrant :<\/p>\n\n<ul class=\"wp-block-list\">\n<li>Une <strong>productivit\u00e9 sup\u00e9rieure<\/strong> par rapport \u00e0 la capture sur prot\u00e9ine A par lots<\/li>\n\n\n\n<li>Une <strong>utilisation de la r\u00e9sine consid\u00e9rablement am\u00e9lior\u00e9e<\/strong>, prolongeant la dur\u00e9e de vie de la r\u00e9sine et r\u00e9duisant le co\u00fbt des marchandises<\/li>\n\n\n\n<li>Une <strong>consommation de tampon r\u00e9duite<\/strong> et des besoins de stockage moindres<\/li>\n\n\n\n<li>Une <strong>architecture simple \u00e0 deux colonnes<\/strong> qui facilite la <strong>validation du proc\u00e9d\u00e9<\/strong> et <strong>l&rsquo;acceptation r\u00e9glementaire<\/strong><\/li>\n\n\n\n<li>Une <strong>performance pr\u00e9visible et \u00e9volutive<\/strong> du d\u00e9veloppement en laboratoire \u00e0 la fabrication pilote et commerciale<\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\">Pour les entreprises mettant en \u0153uvre le <strong>bioproc\u00e9d\u00e9 continu<\/strong>, CaptureSMB offre une voie efficace vers la <strong>capture continue d&rsquo;anticorps monoclonaux \u00e0 l&rsquo;\u00e9chelle industrielle<\/strong> avec des co\u00fbts d&rsquo;exploitation r\u00e9duits et un d\u00e9bit d&rsquo;installation accru.<\/p>\n\n<h2 class=\"wp-block-heading\">\u00c0 propos de ChromaCon AG<\/h2>\n\n<p class=\"wp-block-paragraph\"><strong>ChromaCon AG<\/strong> est une entreprise priv\u00e9e d&rsquo;outils pour les sciences de la vie dont le si\u00e8ge est \u00e0 Zurich, en Suisse, sp\u00e9cialis\u00e9e dans la <strong>chromatographie continue<\/strong> et les <strong>solutions de purification intensifi\u00e9es<\/strong> pour l&rsquo;industrie biopharmaceutique. L&rsquo;entreprise d\u00e9veloppe des <strong>solutions de proc\u00e9d\u00e9 de pointe, un contr\u00f4le de proc\u00e9d\u00e9 dynamique<\/strong> et des <strong>outils de simulation de proc\u00e9d\u00e9<\/strong> pour la purification \u00e0 grande \u00e9chelle de produits biologiques. <\/p>\n\n<p class=\"wp-block-paragraph\">ChromaCon a d\u00e9velopp\u00e9 et brevet\u00e9 de nouveaux <strong>principes de bioproc\u00e9d\u00e9 continu<\/strong> et des <strong>concepts de contr\u00f4le de proc\u00e9d\u00e9 avanc\u00e9s<\/strong> qui g\u00e9n\u00e8rent des \u00e9conomies significatives en CAPEX et OPEX. Ses <strong>syst\u00e8mes Contichrom\u00ae \u00e0 l&rsquo;\u00e9chelle laboratoire<\/strong> sont commercialis\u00e9s dans le monde entier par ChromaCon et ses partenaires, permettant le d\u00e9veloppement efficace de proc\u00e9d\u00e9s de capture et de polissage continus. <\/p>\n\n<p class=\"wp-block-paragraph\">ChromaCon a accord\u00e9 des licences mondiales pour ses technologies de proc\u00e9d\u00e9 continu \u00e0 <strong>LEWA<\/strong> pour leur mise en \u0153uvre dans les syst\u00e8mes de mont\u00e9e en \u00e9chelle <strong>EcoPrime\u00ae Twin<\/strong>, facilitant une transition directe de l&rsquo;\u00e9chelle laboratoire \u00e0 l&rsquo;\u00e9chelle de fabrication.<\/p>\n\n<h3 class=\"wp-block-heading\">Contact ChromaCon<\/h3>\n\n<p class=\"wp-block-paragraph\">Pour en savoir plus sur la <strong>technologie de chromatographie continue CaptureSMB<\/strong> et les <strong>solutions Contichrom<\/strong> de ChromaCon, veuillez contacter :<\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Thomas M\u00fcller-Sp\u00e4th<\/strong><br\/> <a href=\"mailto:info@chromacon.com\">info@chromacon.com<\/a><br\/> <a href=\"https:\/\/www.chromacon.com\/fr\/\" target=\"_blank\" rel=\"noopener\">www.chromacon.com<\/a><\/p>\n<section id=\"block_f1bb5b1191db2a56a352adeca9a3e819\" class=\"block-faq py-fluid-4xl alignfull  \"><div class=\"l-wrap\">\n            <div class=\"block-faq__header mb-fluid-m md:mb-fluid-3xl typo-off\">\n                            <h2 class=\"text-display-m leading-display-m leading-h1 md:text-h1 text-primary-800 text-center mb-fluid-xs\">Questions fr\u00e9quemment pos\u00e9es sur la chromatographie continue \u00e0 deux colonnes CaptureSMB\u00ae<\/h2>\n                                <\/div>\n    \n            <div class=\"block-faq__accordion js-block-faq-accordion flex flex-col gap-fluid-s\">\n                            <div\n                    class=\"block-faq__item bg-white px-[14px] py-[24px] md:py-fluid-m md:px-fluid-l\"\n                    id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-0\"\n                    data-faq-item>\n                    <button \n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-0-trigger\"\n                        class=\"block-faq__trigger appearance-none flex items-center justify-between cursor-pointer select-none w-full text-left\"\n                        aria-expanded=\"false\"\n                        aria-controls=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-0-content\"\n                        aria-label=\"Toggle question: Qu&#039;est-ce que le proc\u00e9d\u00e9 de chromatographie \u00e0 contre-courant p\u00e9riodique \u00e0 deux colonnes CaptureSMB\u00ae pour la purification d&#039;anticorps monoclonaux ?\">\n                        <h3 class=\"!text-h4 md:!m-fluid-2xs text-primary-800 flex-1\">Qu&#039;est-ce que le proc\u00e9d\u00e9 de chromatographie \u00e0 contre-courant p\u00e9riodique \u00e0 deux colonnes CaptureSMB\u00ae pour la purification d&#039;anticorps monoclonaux ?<\/h3>\n\n                        <div class=\"block-faq__icon-wrapper relative shrink-0 ml-4 w-5 h-5\" aria-hidden=\"true\">\n                            <span class=\"block-faq__icon block-faq__icon--plus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-100\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M256 80c0-17.7-14.3-32-32-32s-32 14.3-32 32l0 144L48 224c-17.7 0-32 14.3-32 32s14.3 32 32 32l144 0 0 144c0 17.7 14.3 32 32 32s32-14.3 32-32l0-144 144 0c17.7 0 32-14.3 32-32s-14.3-32-32-32l-144 0 0-144z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                            <span class=\"block-faq__icon block-faq__icon--minus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-0\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M432 256c0 17.7-14.3 32-32 32L48 288c-17.7 0-32-14.3-32-32s14.3-32 32-32l352 0c17.7 0 32 14.3 32 32z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                        <\/div>\n                    <\/button>\n\n                    <div \n                        class=\"block-faq__content-wrapper overflow-hidden h-0\"\n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-0-content\"\n                        role=\"region\"\n                        aria-labelledby=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-0-trigger\"\n                        aria-hidden=\"true\">\n                        <div class=\"block-faq__content pb-1 md:pt-fluid-2xs md:px-fluid-s overflow-y-clip opacity-0 transition-opacity duration-[400ms] ease-in-out\">\n                            <p>CaptureSMB\u00ae est la technologie de capture sur prot\u00e9ine A \u00e0 contre-courant p\u00e9riodique \u00e0 deux colonnes de ChromaCon, con\u00e7ue pour la purification continue d&rsquo;anticorps monoclonaux (mAb). Au lieu d&rsquo;utiliser une seule colonne par lots, deux colonnes sont exploit\u00e9es de mani\u00e8re coordonn\u00e9e, en mode semi-contre-courant. Tandis qu&rsquo;une colonne est charg\u00e9e pr\u00e8s de sa capacit\u00e9 de liaison dynamique, la seconde colonne effectue le lavage, l&rsquo;\u00e9lution et la r\u00e9g\u00e9n\u00e9ration. Cette configuration augmente l&rsquo;utilisation de la r\u00e9sine, permet une charge plus \u00e9lev\u00e9e et offre une productivit\u00e9 nettement sup\u00e9rieure pour la capture de mAb par rapport \u00e0 la chromatographie sur prot\u00e9ine A conventionnelle par lots \u00e0 colonne unique.   <\/p>\n                            \n                                                                                <\/div>\n                    <\/div>\n                <\/div>\n                            <div\n                    class=\"block-faq__item bg-white px-[14px] py-[24px] md:py-fluid-m md:px-fluid-l\"\n                    id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-1\"\n                    data-faq-item>\n                    <button \n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-1-trigger\"\n                        class=\"block-faq__trigger appearance-none flex items-center justify-between cursor-pointer select-none w-full text-left\"\n                        aria-expanded=\"false\"\n                        aria-controls=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-1-content\"\n                        aria-label=\"Toggle question: Comment CaptureSMB a-t-il \u00e9t\u00e9 mis \u00e0 l&#039;\u00e9chelle des syst\u00e8mes de laboratoire Contichrom\u00ae CUBE aux syst\u00e8mes industriels Contichrom\u00ae TWIN ?\">\n                        <h3 class=\"!text-h4 md:!m-fluid-2xs text-primary-800 flex-1\">Comment CaptureSMB a-t-il \u00e9t\u00e9 mis \u00e0 l&#039;\u00e9chelle des syst\u00e8mes de laboratoire Contichrom\u00ae CUBE aux syst\u00e8mes industriels Contichrom\u00ae TWIN ?<\/h3>\n\n                        <div class=\"block-faq__icon-wrapper relative shrink-0 ml-4 w-5 h-5\" aria-hidden=\"true\">\n                            <span class=\"block-faq__icon block-faq__icon--plus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-100\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M256 80c0-17.7-14.3-32-32-32s-32 14.3-32 32l0 144L48 224c-17.7 0-32 14.3-32 32s14.3 32 32 32l144 0 0 144c0 17.7 14.3 32 32 32s32-14.3 32-32l0-144 144 0c17.7 0 32-14.3 32-32s-14.3-32-32-32l-144 0 0-144z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                            <span class=\"block-faq__icon block-faq__icon--minus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-0\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M432 256c0 17.7-14.3 32-32 32L48 288c-17.7 0-32-14.3-32-32s14.3-32 32-32l352 0c17.7 0 32 14.3 32 32z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                        <\/div>\n                    <\/button>\n\n                    <div \n                        class=\"block-faq__content-wrapper overflow-hidden h-0\"\n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-1-content\"\n                        role=\"region\"\n                        aria-labelledby=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-1-trigger\"\n                        aria-hidden=\"true\">\n                        <div class=\"block-faq__content pb-1 md:pt-fluid-2xs md:px-fluid-s overflow-y-clip opacity-0 transition-opacity duration-[400ms] ease-in-out\">\n                            <p>Le proc\u00e9d\u00e9 CaptureSMB a \u00e9t\u00e9 d\u00e9velopp\u00e9 \u00e0 l&rsquo;\u00e9chelle laboratoire sur le syst\u00e8me Contichrom\u00ae CUBE de ChromaCon \u00e0 Zurich, puis transf\u00e9r\u00e9 vers un syst\u00e8me Contichrom\u00ae TWIN 100 fois plus grand, con\u00e7u par LEWA \u00e0 Devens, MA. Une \u00e9quipe conjointe de Bristol-Myers Squibb, ChromaCon et LEWA a d\u00e9montr\u00e9 que les donn\u00e9es de performance des essais CaptureSMB \u00e0 petite \u00e9chelle pr\u00e9disaient avec pr\u00e9cision le comportement \u00e0 l&rsquo;\u00e9chelle pilote et production. Cette transposition directe des param\u00e8tres cl\u00e9s du proc\u00e9d\u00e9 a confirm\u00e9 une strat\u00e9gie de mont\u00e9e en \u00e9chelle robuste et transparente, du d\u00e9veloppement \u00e0 la fabrication industrielle pour la capture continue sur prot\u00e9ine A.  <\/p>\n                            \n                                                                                <\/div>\n                    <\/div>\n                <\/div>\n                            <div\n                    class=\"block-faq__item bg-white px-[14px] py-[24px] md:py-fluid-m md:px-fluid-l\"\n                    id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-2\"\n                    data-faq-item>\n                    <button \n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-2-trigger\"\n                        class=\"block-faq__trigger appearance-none flex items-center justify-between cursor-pointer select-none w-full text-left\"\n                        aria-expanded=\"false\"\n                        aria-controls=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-2-content\"\n                        aria-label=\"Toggle question: Quels sont les principaux avantages en termes de productivit\u00e9 et de co\u00fbt de CaptureSMB par rapport \u00e0 la capture sur prot\u00e9ine A par lots \u00e0 colonne unique ?\">\n                        <h3 class=\"!text-h4 md:!m-fluid-2xs text-primary-800 flex-1\">Quels sont les principaux avantages en termes de productivit\u00e9 et de co\u00fbt de CaptureSMB par rapport \u00e0 la capture sur prot\u00e9ine A par lots \u00e0 colonne unique ?<\/h3>\n\n                        <div class=\"block-faq__icon-wrapper relative shrink-0 ml-4 w-5 h-5\" aria-hidden=\"true\">\n                            <span class=\"block-faq__icon block-faq__icon--plus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-100\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M256 80c0-17.7-14.3-32-32-32s-32 14.3-32 32l0 144L48 224c-17.7 0-32 14.3-32 32s14.3 32 32 32l144 0 0 144c0 17.7 14.3 32 32 32s32-14.3 32-32l0-144 144 0c17.7 0 32-14.3 32-32s-14.3-32-32-32l-144 0 0-144z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                            <span class=\"block-faq__icon block-faq__icon--minus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-0\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M432 256c0 17.7-14.3 32-32 32L48 288c-17.7 0-32-14.3-32-32s14.3-32 32-32l352 0c17.7 0 32 14.3 32 32z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                        <\/div>\n                    <\/button>\n\n                    <div \n                        class=\"block-faq__content-wrapper overflow-hidden h-0\"\n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-2-content\"\n                        role=\"region\"\n                        aria-labelledby=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-2-trigger\"\n                        aria-hidden=\"true\">\n                        <div class=\"block-faq__content pb-1 md:pt-fluid-2xs md:px-fluid-s overflow-y-clip opacity-0 transition-opacity duration-[400ms] ease-in-out\">\n                            <p>Dans l&rsquo;\u00e9tude de mont\u00e9e en \u00e9chelle rapport\u00e9e, le proc\u00e9d\u00e9 CaptureSMB industriel \u00e0 deux colonnes a permis d&rsquo;obtenir une productivit\u00e9 environ 2,5 fois sup\u00e9rieure par rapport \u00e0 la capture sur prot\u00e9ine A conventionnelle par lots \u00e0 colonne unique, mesur\u00e9e en grammes de mAb produits par litre de r\u00e9sine par heure. L&rsquo;utilisation de la r\u00e9sine est pass\u00e9e d&rsquo;environ 67 % \u00e0 92 %, maximisant la valeur et la dur\u00e9e de vie des supports chromatographiques co\u00fbteux. De plus, la consommation de tampon a \u00e9t\u00e9 r\u00e9duite d&rsquo;environ 50 %, ce qui diminue directement les co\u00fbts d&rsquo;exploitation, les besoins de stockage de tampon et l&#8217;empreinte globale de l&rsquo;installation. Ensemble, ces gains contribuent \u00e0 r\u00e9duire le co\u00fbt des marchandises (COGS) et \u00e0 augmenter le d\u00e9bit de l&rsquo;installation dans la fabrication commerciale d&rsquo;anticorps monoclonaux.   <\/p>\n                            \n                                                                                <\/div>\n                    <\/div>\n                <\/div>\n                            <div\n                    class=\"block-faq__item bg-white px-[14px] py-[24px] md:py-fluid-m md:px-fluid-l\"\n                    id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-3\"\n                    data-faq-item>\n                    <button \n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-3-trigger\"\n                        class=\"block-faq__trigger appearance-none flex items-center justify-between cursor-pointer select-none w-full text-left\"\n                        aria-expanded=\"false\"\n                        aria-controls=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-3-content\"\n                        aria-label=\"Toggle question: Le proc\u00e9d\u00e9 CaptureSMB \u00e0 deux colonnes est-il adapt\u00e9 \u00e0 la fabrication BPF et \u00e0 la validation r\u00e9glementaire ?\">\n                        <h3 class=\"!text-h4 md:!m-fluid-2xs text-primary-800 flex-1\">Le proc\u00e9d\u00e9 CaptureSMB \u00e0 deux colonnes est-il adapt\u00e9 \u00e0 la fabrication BPF et \u00e0 la validation r\u00e9glementaire ?<\/h3>\n\n                        <div class=\"block-faq__icon-wrapper relative shrink-0 ml-4 w-5 h-5\" aria-hidden=\"true\">\n                            <span class=\"block-faq__icon block-faq__icon--plus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-100\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M256 80c0-17.7-14.3-32-32-32s-32 14.3-32 32l0 144L48 224c-17.7 0-32 14.3-32 32s14.3 32 32 32l144 0 0 144c0 17.7 14.3 32 32 32s32-14.3 32-32l0-144 144 0c17.7 0 32-14.3 32-32s-14.3-32-32-32l-144 0 0-144z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                            <span class=\"block-faq__icon block-faq__icon--minus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-0\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M432 256c0 17.7-14.3 32-32 32L48 288c-17.7 0-32-14.3-32-32s14.3-32 32-32l352 0c17.7 0 32 14.3 32 32z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                        <\/div>\n                    <\/button>\n\n                    <div \n                        class=\"block-faq__content-wrapper overflow-hidden h-0\"\n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-3-content\"\n                        role=\"region\"\n                        aria-labelledby=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-3-trigger\"\n                        aria-hidden=\"true\">\n                        <div class=\"block-faq__content pb-1 md:pt-fluid-2xs md:px-fluid-s overflow-y-clip opacity-0 transition-opacity duration-[400ms] ease-in-out\">\n                            <p>Oui. Un avantage cl\u00e9 de CaptureSMB est son architecture simple \u00e0 deux colonnes, plus facile \u00e0 comprendre, valider et documenter que les syst\u00e8mes multi-colonnes plus complexes. Selon Thomas M\u00fcller-Sp\u00e4th, directeur des op\u00e9rations de ChromaCon, la faible complexit\u00e9 du proc\u00e9d\u00e9 et la mont\u00e9e en \u00e9chelle pr\u00e9visible sont des facteurs importants pour la validation du proc\u00e9d\u00e9 et l&rsquo;approbation r\u00e9glementaire. La d\u00e9monstration industrielle r\u00e9ussie sur la plateforme Contichrom\u00ae TWIN, combin\u00e9e \u00e0 l&rsquo;utilisation de r\u00e9sines prot\u00e9ine A et de mat\u00e9riel bien \u00e9tablis, positionne CaptureSMB comme une solution pratique pour le traitement en aval continu conforme aux BPF d&rsquo;anticorps monoclonaux th\u00e9rapeutiques.   <\/p>\n                            \n                                                                                <\/div>\n                    <\/div>\n                <\/div>\n                            <div\n                    class=\"block-faq__item bg-white px-[14px] py-[24px] md:py-fluid-m md:px-fluid-l\"\n                    id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-4\"\n                    data-faq-item>\n                    <button \n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-4-trigger\"\n                        class=\"block-faq__trigger appearance-none flex items-center justify-between cursor-pointer select-none w-full text-left\"\n                        aria-expanded=\"false\"\n                        aria-controls=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-4-content\"\n                        aria-label=\"Toggle question: Comment les entreprises biopharmaceutiques peuvent-elles mettre en \u0153uvre la chromatographie continue CaptureSMB \u00e0 l&#039;\u00e9chelle industrielle ?\">\n                        <h3 class=\"!text-h4 md:!m-fluid-2xs text-primary-800 flex-1\">Comment les entreprises biopharmaceutiques peuvent-elles mettre en \u0153uvre la chromatographie continue CaptureSMB \u00e0 l&#039;\u00e9chelle industrielle ?<\/h3>\n\n                        <div class=\"block-faq__icon-wrapper relative shrink-0 ml-4 w-5 h-5\" aria-hidden=\"true\">\n                            <span class=\"block-faq__icon block-faq__icon--plus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-100\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M256 80c0-17.7-14.3-32-32-32s-32 14.3-32 32l0 144L48 224c-17.7 0-32 14.3-32 32s14.3 32 32 32l144 0 0 144c0 17.7 14.3 32 32 32s32-14.3 32-32l0-144 144 0c17.7 0 32-14.3 32-32s-14.3-32-32-32l-144 0 0-144z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                            <span class=\"block-faq__icon block-faq__icon--minus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-0\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M432 256c0 17.7-14.3 32-32 32L48 288c-17.7 0-32-14.3-32-32s14.3-32 32-32l352 0c17.7 0 32 14.3 32 32z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                        <\/div>\n                    <\/button>\n\n                    <div \n                        class=\"block-faq__content-wrapper overflow-hidden h-0\"\n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-4-content\"\n                        role=\"region\"\n                        aria-labelledby=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-4-trigger\"\n                        aria-hidden=\"true\">\n                        <div class=\"block-faq__content pb-1 md:pt-fluid-2xs md:px-fluid-s overflow-y-clip opacity-0 transition-opacity duration-[400ms] ease-in-out\">\n                            <p>Les fabricants biopharmaceutiques peuvent commencer par le d\u00e9veloppement du proc\u00e9d\u00e9 sur les syst\u00e8mes Contichrom\u00ae \u00e0 l&rsquo;\u00e9chelle laboratoire de ChromaCon pour optimiser les conditions CaptureSMB pour leur anticorps monoclonal sp\u00e9cifique. Les m\u00eames principes de proc\u00e9d\u00e9 peuvent ensuite \u00eatre transf\u00e9r\u00e9s directement vers les syst\u00e8mes EcoPrime\u00ae Twin et Contichrom\u00ae TWIN de LEWA pour la fabrication \u00e0 l&rsquo;\u00e9chelle pilote et commerciale. ChromaCon fournit le savoir-faire en mati\u00e8re de proc\u00e9d\u00e9, les strat\u00e9gies de contr\u00f4le dynamique et les outils de simulation, tandis que des partenaires sous licence tels que LEWA fournissent le mat\u00e9riel industriel. Ensemble, ils offrent une voie int\u00e9gr\u00e9e du d\u00e9veloppement en laboratoire \u00e0 la production BPF valid\u00e9e, permettant une adoption rapide du traitement en aval continu et de la capture sur prot\u00e9ine A \u00e0 deux colonnes.   <\/p>\n                            \n                                                                                <\/div>\n                    <\/div>\n                <\/div>\n                            <div\n                    class=\"block-faq__item bg-white px-[14px] py-[24px] md:py-fluid-m md:px-fluid-l\"\n                    id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-5\"\n                    data-faq-item>\n                    <button \n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-5-trigger\"\n                        class=\"block-faq__trigger appearance-none flex items-center justify-between cursor-pointer select-none w-full text-left\"\n                        aria-expanded=\"false\"\n                        aria-controls=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-5-content\"\n                        aria-label=\"Toggle question: Qu&#039;est-ce qui fait de CaptureSMB une option attractive pour les entreprises adoptant le bioproc\u00e9d\u00e9 continu ?\">\n                        <h3 class=\"!text-h4 md:!m-fluid-2xs text-primary-800 flex-1\">Qu&#039;est-ce qui fait de CaptureSMB une option attractive pour les entreprises adoptant le bioproc\u00e9d\u00e9 continu ?<\/h3>\n\n                        <div class=\"block-faq__icon-wrapper relative shrink-0 ml-4 w-5 h-5\" aria-hidden=\"true\">\n                            <span class=\"block-faq__icon block-faq__icon--plus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-100\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M256 80c0-17.7-14.3-32-32-32s-32 14.3-32 32l0 144L48 224c-17.7 0-32 14.3-32 32s14.3 32 32 32l144 0 0 144c0 17.7 14.3 32 32 32s32-14.3 32-32l0-144 144 0c17.7 0 32-14.3 32-32s-14.3-32-32-32l-144 0 0-144z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                            <span class=\"block-faq__icon block-faq__icon--minus absolute top-0 left-0 w-full h-full flex items-center justify-center transition-opacity duration-300 ease-in-out opacity-0\">\n                                <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 448 512\" class=\"svg-inline--fa w-5 h-5\" role=\"img\" aria-hidden=\"true\" style=\"color:currentColor\"><!--! Font Awesome Free 6.7.2 by @fontawesome - https:\/\/fontawesome.com License - https:\/\/fontawesome.com\/license\/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d=\"M432 256c0 17.7-14.3 32-32 32L48 288c-17.7 0-32-14.3-32-32s14.3-32 32-32l352 0c17.7 0 32 14.3 32 32z\" fill=\"currentColor\"><\/path><\/svg>\n                            <\/span>\n                        <\/div>\n                    <\/button>\n\n                    <div \n                        class=\"block-faq__content-wrapper overflow-hidden h-0\"\n                        id=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-5-content\"\n                        role=\"region\"\n                        aria-labelledby=\"faq-item-block_f1bb5b1191db2a56a352adeca9a3e819-5-trigger\"\n                        aria-hidden=\"true\">\n                        <div class=\"block-faq__content pb-1 md:pt-fluid-2xs md:px-fluid-s overflow-y-clip opacity-0 transition-opacity duration-[400ms] ease-in-out\">\n                            <p>CaptureSMB combine les avantages de la chromatographie continue avec une configuration simple \u00e0 deux colonnes. Pour les entreprises mettant en \u0153uvre le bioproc\u00e9d\u00e9 continu, il offre une productivit\u00e9 sup\u00e9rieure, une utilisation am\u00e9lior\u00e9e de la r\u00e9sine, une consommation de tampon r\u00e9duite et une plateforme \u00e9volutive du laboratoire \u00e0 la fabrication \u00e0 grande \u00e9chelle. Ces caract\u00e9ristiques favorisent des co\u00fbts d&rsquo;exploitation r\u00e9duits, un d\u00e9bit d&rsquo;installation accru et une voie r\u00e9glementaire plus fluide par rapport aux syst\u00e8mes multi-colonnes plus complexes. Comme d\u00e9montr\u00e9 en collaboration avec Bristol-Myers Squibb et LEWA, CaptureSMB fournit une solution \u00e9prouv\u00e9e et pr\u00eate pour l&rsquo;industrie pour la capture continue d&rsquo;anticorps monoclonaux \u00e0 l&rsquo;\u00e9chelle industrielle.   <\/p>\n                            \n                                                                                <\/div>\n                    <\/div>\n                <\/div>\n                    <\/div>\n    \n<\/div><\/section>","protected":false},"excerpt":{"rendered":"<p>Une \u00e9quipe conjointe de Bristol-Myers Squibb, ChromaCon et LEWA rapporte le succ\u00e8s de la mont\u00e9e en \u00e9chelle du proc\u00e9d\u00e9 de chromatographie continue CaptureSMB pour la purification d&rsquo;anticorps monoclonaux. La mont\u00e9e en \u00e9chelle d&rsquo;un facteur 100 a permis d&rsquo;obtenir une productivit\u00e9 2,5 fois sup\u00e9rieure et une r\u00e9duction de 50 % de la consommation de tampon par rapport \u00e0 la capture conventionnelle par lots. <\/p>\n","protected":false},"author":2,"featured_media":17765,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"","_seopress_redirections_param":"","_seopress_redirections_type":0,"_seopress_analysis_target_kw":"","_seopress_news_disabled":"","_seopress_video_disabled":"","_seopress_video":[],"_seopress_pro_schemas_manual":[],"_seopress_pro_rich_snippets_disable_all":"","_seopress_pro_rich_snippets_disable":[],"_seopress_pro_schemas":[],"footnotes":""},"categories":[311],"tags":[335,334],"class_list":["post-17763","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-actualites","tag-montee-en-echelle","tag-capturesmb"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/posts\/17763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/comments?post=17763"}],"version-history":[{"count":1,"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/posts\/17763\/revisions"}],"predecessor-version":[{"id":17767,"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/posts\/17763\/revisions\/17767"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/media\/17765"}],"wp:attachment":[{"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/media?parent=17763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/categories?post=17763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chromacon.com\/fr\/wp-json\/wp\/v2\/tags?post=17763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}